Olivari N
FA für Plastische Chirurgie , Hauptstr. 269, 51503, Rösrath, Deutschland.
HNO. 2010 Jan;58(1):8-10, 12-4. doi: 10.1007/s00106-009-2025-x.
Since the transpalpebral decompression of the orbit by removal of intraorbital fat was introduced in 1985, this technique has become the state of the art in surgical therapy for Graves' ophthalmopathy at the authors' institution. Our experience with a series of 3,210 orbital decompressions in 1,635 patients with endocrine ophthalmopathy represents the largest collective of such patients that has been published yet to our knowledge. Over time the technique has proved to be reliable, effective, safe, and easily performed by a trained and experienced oculoplastic surgeon with long-lasting results, leading to improvement not only in visual function but also in well-being and in patients' social life, with a high benefit to low risk ratio. The promising and satisfying results demonstrated earliest in 1988 have been confirmed in further evaluation at our clinic and others. In summary, this technique, which is associated with very low morbidity, is our method of choice in moderate to severe cases of exophthalmos and even in functionally asymptomatic patients with mild to moderate aesthetic impairment. However, it has to be emphasized that this complex and multifactorial disorder often requires a broad range of long-term medical attendance. Postoperatively the majority of patients showed significant improvements of ocular protrusion, diplopia, visual acuity, swelling of eyelids, headache and retrobulbar "burn". In very rare instances, the surgical technique can be performed as a one-stage procedure. In severe cases (proptosis >28 or extreme muscle hypertrophy), lipectomy can be combined with expansion of the bony orbital cavity (<1% patients).
自1985年引入经睑眶减压术(通过去除眶内脂肪)以来,在作者所在机构,这项技术已成为Graves眼病手术治疗的先进技术。我们对1635例内分泌性眼病患者进行了一系列3210次眶减压手术,据我们所知,这是已发表的此类患者的最大群体。随着时间的推移,该技术已被证明是可靠、有效、安全的,并且经过培训和经验丰富的眼整形医生可以轻松实施,效果持久,不仅能改善视觉功能,还能提高患者的幸福感和社交生活质量,受益风险比很高。1988年最早证明的有前景且令人满意的结果在我们诊所和其他机构的进一步评估中得到了证实。总之,这项发病率极低的技术是我们治疗中度至重度眼球突出病例,甚至是轻度至中度美学受损的功能无症状患者的首选方法。然而,必须强调的是,这种复杂的多因素疾病通常需要广泛的长期医疗护理。术后大多数患者的眼球突出、复视、视力、眼睑肿胀、头痛和球后“烧灼感”都有显著改善。在极少数情况下,手术可作为一期手术进行。在严重病例(眼球突出>28或肌肉极度肥大)中,脂肪切除术可与眼眶骨腔扩大术联合进行(<1%的患者)。